Digestive & Intestinal Remedies (Pharmacies) - Israel

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$46.97m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.91%, resulting in a market volume of US$51.64m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$5.04 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Israel has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Israeli consumers are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This shift in preferences can be attributed to a growing awareness of the potential side effects associated with conventional pharmaceutical products. As a result, there has been a surge in demand for natural digestive and intestinal remedies, such as herbal teas, probiotics, and dietary supplements.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Israel is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are commonly found in yogurt and other fermented foods, as well as in dietary supplements. The increasing awareness of the importance of gut health and the role of probiotics in maintaining a healthy digestive system has fueled the demand for probiotic products in Israel. Another trend in the market is the growing popularity of herbal teas for digestive and intestinal issues. Herbal teas, such as chamomile, peppermint, and ginger, have long been used as natural remedies for digestive problems. Israeli consumers are increasingly turning to these herbal teas as a natural and soothing solution for digestive discomfort.

Local special circumstances: Israel has a high prevalence of digestive and intestinal disorders, which has contributed to the growth of the Digestive & Intestinal Remedies market. This can be attributed to factors such as a Western diet, stress, and a sedentary lifestyle. The high prevalence of these disorders has created a need for effective remedies, driving the demand for Digestive & Intestinal Remedies in the country.

Underlying macroeconomic factors: The growing Digestive & Intestinal Remedies market in Israel can also be attributed to favorable macroeconomic factors. Israel has a strong and stable economy, which has led to increased disposable income among consumers. This has enabled them to spend more on healthcare and wellness products, including Digestive & Intestinal Remedies. Additionally, the Israeli government has been supportive of the healthcare sector, investing in research and development, and promoting the use of natural remedies. These factors have created a conducive environment for the growth of the Digestive & Intestinal Remedies market in Israel. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Israel has experienced significant growth due to changing customer preferences, local special circumstances, and favorable macroeconomic factors. The demand for natural and herbal remedies, such as probiotics and herbal teas, has been on the rise, driven by a growing awareness of the potential side effects of conventional pharmaceutical products. The high prevalence of digestive and intestinal disorders in Israel has also contributed to the growth of the market. Additionally, favorable macroeconomic factors, such as a strong economy and government support, have further fueled the growth of the Digestive & Intestinal Remedies market in Israel.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.